[go: up one dir, main page]

WO2007098183A3 - Treatment of cancer with 2-deoxygalactose - Google Patents

Treatment of cancer with 2-deoxygalactose Download PDF

Info

Publication number
WO2007098183A3
WO2007098183A3 PCT/US2007/004465 US2007004465W WO2007098183A3 WO 2007098183 A3 WO2007098183 A3 WO 2007098183A3 US 2007004465 W US2007004465 W US 2007004465W WO 2007098183 A3 WO2007098183 A3 WO 2007098183A3
Authority
WO
WIPO (PCT)
Prior art keywords
deoxygalactose
cancer
treatment
outcom
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/004465
Other languages
French (fr)
Other versions
WO2007098183A2 (en
Inventor
Bernard R Landau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002655614A priority Critical patent/CA2655614A1/en
Priority to AU2007217764A priority patent/AU2007217764A1/en
Priority to EP07751239A priority patent/EP2049125A2/en
Publication of WO2007098183A2 publication Critical patent/WO2007098183A2/en
Publication of WO2007098183A3 publication Critical patent/WO2007098183A3/en
Priority to US12/196,195 priority patent/US20090163442A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

2-Deoxygalactose and its analogs can be used to treat cancer and to improve patient outcom when administered in therapeutically effective doses alone or in combination with other anti cancer drugs or with surgical resection or radiation therapy.
PCT/US2007/004465 2006-02-21 2007-02-21 Treatment of cancer with 2-deoxygalactose Ceased WO2007098183A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002655614A CA2655614A1 (en) 2006-02-21 2007-02-21 Treatment of cancer with 2-deoxygalactose
AU2007217764A AU2007217764A1 (en) 2006-02-21 2007-02-21 Treatment of cancer with 2-deoxygalactose
EP07751239A EP2049125A2 (en) 2006-02-21 2007-02-21 Treatment of cancer with 2-deoxygalactose
US12/196,195 US20090163442A1 (en) 2007-02-21 2008-08-21 Treatment of cancer with 2-deoxygalactose

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77563006P 2006-02-21 2006-02-21
US60/775,630 2006-02-21

Publications (2)

Publication Number Publication Date
WO2007098183A2 WO2007098183A2 (en) 2007-08-30
WO2007098183A3 true WO2007098183A3 (en) 2007-12-13

Family

ID=38437961

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/004465 Ceased WO2007098183A2 (en) 2006-02-21 2007-02-21 Treatment of cancer with 2-deoxygalactose

Country Status (5)

Country Link
EP (1) EP2049125A2 (en)
CN (1) CN101437523A (en)
AU (1) AU2007217764A1 (en)
CA (1) CA2655614A1 (en)
WO (1) WO2007098183A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264352A (en) * 1991-04-09 1993-11-23 Hoechst Aktiengesellschaft Process for the enzymatic synthesis of 2-deoxy-β-D-galactosides
US5591429A (en) * 1993-07-26 1997-01-07 The United States Of America As Represented By The Secretary Of Agriculture Composition containing 2-deoxy-D-glucose and Candida saitoana and a method of use for the biological control of postharvest diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264352A (en) * 1991-04-09 1993-11-23 Hoechst Aktiengesellschaft Process for the enzymatic synthesis of 2-deoxy-β-D-galactosides
US5591429A (en) * 1993-07-26 1997-01-07 The United States Of America As Represented By The Secretary Of Agriculture Composition containing 2-deoxy-D-glucose and Candida saitoana and a method of use for the biological control of postharvest diseases

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] LASZLO ET AL.: "Effects of glucose analogs (2-deoxy-D-glucose, 2-deoxy-D-galactose) on experimental tumors", XP008138233, accession no. STN Database accession no. (1961:19261 *
JOURNAL OF THE NATIONAL CANCER INSTITUTE (1940-1978), vol. 24, 1960, pages 267 - 279 *
KO ET AL.: "Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase", CANCER LETTERS, vol. 173, 2001, pages 83 - 91, XP002365255 *

Also Published As

Publication number Publication date
EP2049125A2 (en) 2009-04-22
AU2007217764A1 (en) 2007-08-30
CN101437523A (en) 2009-05-20
WO2007098183A2 (en) 2007-08-30
CA2655614A1 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
WO2004062604A3 (en) Treatment of cancer with 2-deoxyglucose
WO2012045090A3 (en) Therapeutic use of a tlr agonist and combination therapy
MX2011007589A (en) Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody.
WO2009099634A3 (en) Picoplatin and amrubicin to treat lung cancer
WO2004064734A3 (en) Combination therapies for the treatment of cancer
WO2011146777A3 (en) Device and method for providing a synergistic combination of phototherapy and a non-light energy modality to the brain
PH12013501790B1 (en) Use of dpp iv inhibitors
EP2759302A3 (en) 4F-benzoyl-TN14003 combined with rituximab for use in the treatment of a tumour
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
WO2011041632A3 (en) Combination therapies for the treatment of obesity
WO2016090024A3 (en) Combination therapy for treatment of cancer
BR112013007423A2 (en) combination therapy with regard to the treatment of hcv infection
MX2009003532A (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin.
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
WO2010019717A3 (en) Combination therapy of hiv fusion/entry inhibitors targeting gp41
WO2007130501A3 (en) Combination therapy for treatment of cancer
BRPI0510895A (en) 10-propargyl-10-deazaaminopterin pharmaceutical formulation for t-cell lymphoma treatment
TW200633700A (en) Methods of using temozolomide formulation intrathecally in the treatment of cancers
WO2011009115A3 (en) Combination therapies for the treatment of obesity
PL1732551T3 (en) Perhexilin for treating chronic heart failure
MX2009009230A (en) Use of silodosin in a once daily administration for treating benign prostatic hyperplasia.
ATE330600T1 (en) COMBINATION PREPARATION FOR CANCER THERAPY
WO2006124573A3 (en) Treatment of cancer with 2-deoxyglucose
WO2007098183A3 (en) Treatment of cancer with 2-deoxygalactose
BRPI0508982A (en) use of azd2171 or a pharmaceutically acceptable salt thereof excluding an azd2171 maleate salt, pharmaceutical composition, kit, method for treating a cancer in a warm-blooded animal such as a human, and use of azd2171 maleate salt azd2171 and 5 - fu and cpt - 11

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007217764

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2655614

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2007217764

Country of ref document: AU

Date of ref document: 20070221

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 200780009673.1

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2007751239

Country of ref document: EP